2022 Full Year Guidance and Strategic Outlook

Progress on Strategic Priorities Transforming Envista into a higher growth, higher margin company Priority Accelerate growth through strategic organic investments Expand operating margins through disciplined execution and reductions in structural costs Building a better, stronger, growth- oriented portfolio . Results . . • Continued strength in orthodontics; Spark core sales growth* >100% vs. Q1 2021 Implants delivered HSD core sales growth*, despite lockdown in Shanghai in last week of quarter Innovation delivering >350 bps in core sales growth* driven by Spark, N1, and Damon Ultima Achieved 19.7% Adjusted EBITDA margin*; up 120 bps sequentially vs. Q4 2021 • EBS continues to drive reduction in structural costs Continue to invest in long-term strategic priorities Closed the acquisition of Carestream intraoral scanner business (post-Q1) Rebranded Imaging portfolio to Dexis Strong balance sheet; significant flexibility for capital deployment 4 *Core sales growth and adjusted EBITDA margins are non-GAAP financial measures. For a reconciliation to the most directly comparable GAAP measures, please see Appendix. Envista

View entire presentation